177
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Tracking the Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in an Emergency Intensive Care Unit by Whole Genome Sequencing

, , , &
Pages 6215-6224 | Received 19 Aug 2022, Accepted 19 Oct 2022, Published online: 27 Oct 2022

References

  • Chang SL, Dela Cruz CS, Zhang D, Zhang D. Clinical epidemiology, risk factors, and control strategies of Klebsiella pneumoniae infection. Front Microbiol. 2021;12:750662. doi:10.3389/fmicb.2021.750662
  • de Oliveira Santos JV, da Costa Junior SD, de Fatima Ramos Dos Santos Medeiros SM, et al. Panorama of bacterial infections caused by epidemic resistant strains. Curr Microbiol. 2022;79(6):175. doi:10.1007/s00284-022-02875-9
  • Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785–796. doi:10.1016/S1473-3099(13)70190-7
  • Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–1161. doi:10.1128/AAC.45.4.1151-1161.2001
  • Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007;51(2):763–765. doi:10.1128/AAC.01053-06
  • Fu P, Tang Y, Li G, Yu L, Wang Y, Jiang X. Pandemic spread of blaKPC-2 among Klebsiella pneumoniae ST11 in China is associated with horizontal transfer mediated by IncFII-like plasmids. Int J Antimicrob Agents. 2019;54(2):117–124. doi:10.1016/j.ijantimicag.2019.03.014
  • Qi Y, Wei Z, Ji S, Du X, Shen P, Yu Y. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother. 2011;66(2):307–312. doi:10.1093/jac/dkq431
  • Zhang R, Liu L, Zhou H, et al. Nationwide surveillance of clinical carbapenem-resistant enterobacteriaceae (CRE) strains in China. EBioMedicine. 2017;19:98–106. doi:10.1016/j.ebiom.2017.04.032
  • Hu F, Zhu D, Wang F, Wang M. Current status and trends of antibacterial resistance in China. Clin Infect Dis. 2018;67(suppl_2):S128–S134. doi:10.1093/cid/ciy657
  • Chi X, Hu G, Xu H, et al. Genomic analysis of a KPC-2-producing Klebsiella pneumoniae ST11 outbreak from a teaching hospital in Shandong Province, China. Infect Drug Resist. 2019;12:2961–2969. doi:10.2147/IDR.S221788
  • Zhang M, Li J, Lu Y, et al. Expanding of ST11 carbapenemase-producing Klebsiella pneumoniae subclones in a Chinese Hospital, Shenzhen, China. Infect Drug Resist. 2021;14:1415–1422. doi:10.2147/IDR.S299478
  • Sui W, Zhou H, Du P, et al. Whole genome sequence revealed the fine transmission map of carbapenem-resistant Klebsiella pneumonia isolates within a nosocomial outbreak. Antimicrob Resist Infect Control. 2018;7(1):70. doi:10.1186/s13756-018-0363-8
  • Chen C, Zhang Y, Yu SL, et al. Tracking carbapenem-producing Klebsiella pneumoniae outbreak in an intensive care unit by whole genome sequencing. Front Cell Infect Microbiol. 2019;9:281. doi:10.3389/fcimb.2019.00281
  • Yang Y, Chen J, Lin D, Xu X, Cheng J, Sun C. Prevalence and drug resistance characteristics of carbapenem-resistant Enterobacteriaceae in Hangzhou, China. Front Med. 2018;12(2):182–188. doi:10.1007/s11684-017-0529-4
  • Liu J, Yu J, Chen F, et al. Emergence and establishment of KPC-2-producing ST11 Klebsiella pneumoniae in a general hospital in Shanghai, China. Eur J Clin Microbiol Infect Dis. 2018;37(2):293–299. doi:10.1007/s10096-017-3131-4
  • Jiang Y, Wei Z, Wang Y, Hua X, Feng Y, Yu Y. Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole genome sequencing. Clin Microbiol Infect. 2015;21(11):1001–1007. doi:10.1016/j.cmi.2015.07.001
  • Hu H, Mao J, Chen Y, et al. Clinical and microbiological characteristics of community-onset carbapenem-resistant enterobacteriaceae isolates. Infect Drug Resist. 2020;13:3131–3143. doi:10.2147/IDR.S260804
  • Qiu Y, Lin D, Xu Y, et al. Invasive Klebsiella pneumoniae infections in community-settings and healthcare settings. Infect Drug Resist. 2021;14:2647–2656. doi:10.2147/IDR.S315871
  • Sfeir MM, Satlin MJ, Fauntleroy KA, Jenkins SG, Westblade LF. Blood-modified carbapenem inactivation method: a phenotypic method for detecting carbapenemase-producing enterobacteriaceae directly from positive blood culture broths. J Clin Microbiol. 2020;58(2). doi:10.1128/JCM.01377-19
  • Agyeman AA, Bergen PJ, Rao GG, Nation RL, Landersdorfer CB. A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. Int J Antimicrob Agents. 2020;55(1):105833. doi:10.1016/j.ijantimicag.2019.10.014
  • Liao W, Liu Y, Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years. J Glob Antimicrob Resist. 2020;23:174–180. doi:10.1016/j.jgar.2020.09.004
  • Liu Y, Zhang X, Cai L, Zong Z. Enhanced survival of ST-11 carbapenem-resistant Klebsiella pneumoniae in the intensive care unit. Infect Control Hosp Epidemiol. 2020;41(6):740–742. doi:10.1017/ice.2020.68
  • Simar SR, Hanson BM, Arias CA. Techniques in bacterial strain typing: past, present, and future. Curr Opin Infect Dis. 2021;34(4):339–345. doi:10.1097/QCO.0000000000000743
  • Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4(148):148ra116. doi:10.1126/scitranslmed.3004129
  • Tielen P, Rosin N, Meyer AK, et al. Regulatory and metabolic networks for the adaptation of Pseudomonas aeruginosa biofilms to urinary tract-like conditions. PLoS One. 2013;8(8):e71845. doi:10.1371/journal.pone.0071845
  • Zhao D, Shi Q, Hu D, et al. The emergence of novel sequence type strains reveals an evolutionary process of intraspecies clone shifting in ICU-spreading carbapenem-resistant Klebsiella pneumoniae. Front Microbiol. 2021;12:691406. doi:10.3389/fmicb.2021.691406
  • Chen L, Kreiswirth BN. Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae. Lancet Infect Dis. 2018;18(1):2–3. doi:10.1016/S1473-3099(17)30517-0
  • Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37–46. doi:10.1016/S1473-3099(17)30489-9
  • Zimmerman FS, Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41(3):190–194. doi:10.1016/j.ajic.2012.09.020
  • Changruenngam S, Modchang C, Bicout DJ. Modelling of the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae in hospitals and design of control strategies. Sci Rep. 2022;12(1):3805. doi:10.1038/s41598-022-07728-w
  • Spyridopoulou K, Psichogiou M, Sypsa V, et al. Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting. Antimicrob Resist Infect Control. 2020;9(1):102. doi:10.1186/s13756-020-00766-x
  • Sharma S, Banerjee T, Kumar A, Yadav G, Basu S. Extensive outbreak of colistin resistant, carbapenemase (blaOXA-48, blaNDM) producing Klebsiella pneumoniae in a large tertiary care hospital, India. Antimicrob Resist Infect Control. 2022;11(1):1. doi:10.1186/s13756-021-01048-w
  • Shao C, Jin Y, Wang W, Jiang M, Zhao S. An outbreak of carbapenem-resistant Klebsiella pneumoniae of K57 capsular serotype in an emergency intensive care unit of a teaching hospital in China. Front Public Health. 2021;9:724212. doi:10.3389/fpubh.2021.724212
  • Wei L, Wu L, Wen H, et al. Spread of carbapenem-resistant Klebsiella pneumoniae in an intensive care unit: a whole-genome sequence-based prospective observational study. Microbiol Spectr. 2021;9(1):e0005821. doi:10.1128/Spectrum.00058-21